Business Description
BerGenBio ASA
ISIN : NO0013251173
Compare
Compare
Traded in other countries / regions
BGBIO.Norway7BG0.Germany0RU5.UKBGBIOO.SwedenBRRGF.USA IPO Date
2018-07-18Description
BerGenBio ASA is a clinical-stage biopharmaceutical Company focused on developing novel medicines for aggressive diseases. The company's clinical asset, bemcentinib, targeting the receptor tyrosine kinase AXL, is currently in development in a Ph1b/2a study in 1L STK 11 mutated NSCLC and preclinical development for severe respiratory infections.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 478.75 | |||||
| Equity-to-Asset | 0.8 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 5.03 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -66.9 | |||||
| 3-Year EBITDA Growth Rate | 64.5 | |||||
| 3-Year EPS without NRI Growth Rate | 64.7 | |||||
| 3-Year FCF Growth Rate | 61.2 | |||||
| 3-Year Book Growth Rate | -80.7 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 12-1 Month Momentum % | -98.59 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.05 | |||||
| Quick Ratio | 5.05 | |||||
| Cash Ratio | 4.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -198.5 | |||||
| Shareholder Yield % | -32.25 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -31124.18 | |||||
| Net Margin % | -29828.22 | |||||
| FCF Margin % | -31342 | |||||
| ROE % | -104.26 | |||||
| ROA % | -81.22 | |||||
| ROIC % | -728.93 | |||||
| ROC (Joel Greenblatt) % | -51504.22 | |||||
| ROCE % | -106.34 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 578.95 | |||||
| PB Ratio | 2.45 | |||||
| Price-to-Tangible-Book | 2.45 | |||||
| EV-to-EBIT | -1.97 | |||||
| EV-to-Forward-EBIT | -1.86 | |||||
| EV-to-EBITDA | -1.98 | |||||
| EV-to-Forward-EBITDA | -1.86 | |||||
| EV-to-Revenue | 600.02 | |||||
| EV-to-FCF | -1.87 | |||||
| Price-to-Net-Current-Asset-Value | 2.46 | |||||
| Price-to-Net-Cash | 2.75 | |||||
| Earnings Yield (Greenblatt) % | -50.76 | |||||
| FCF Yield % | -38.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BRRGF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BerGenBio ASA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.05 | ||
| EPS (TTM) ($) | -0.465 | ||
| Beta | -0.98 | ||
| Volatility % | 98.59 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0.000017 | ||
| 20-Day SMA ($) | 2.5 | ||
| 12-1 Month Momentum % | -98.59 | ||
| 52-Week Range ($) | 2.5 - 177 | ||
| Shares Outstanding (Mil) | 39.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BerGenBio ASA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BerGenBio ASA Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
BerGenBio ASA Frequently Asked Questions
What is BerGenBio ASA(BRRGF)'s stock price today?
The current price of BRRGF is $2.50. The 52 week high of BRRGF is $177.00 and 52 week low is $2.50.
When is next earnings date of BerGenBio ASA(BRRGF)?
The next earnings date of BerGenBio ASA(BRRGF) is 2024-11-13.
Does BerGenBio ASA(BRRGF) pay dividends? If so, how much?
BerGenBio ASA(BRRGF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers